Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report issued on Friday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

NYSE:AMPE opened at $0.00 on Friday. The stock has a market capitalization of $2,508.00, a PE ratio of 0.00 and a beta of 3.73. Ampio Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $7.47.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.